11 – 20 of 833
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Consensus Guidance for Monitoring Individuals With Islet Autoantibody-Positive Pre-Stage 3 Type 1 Diabetes
(
- Contribution to journal › Article
-
Mark
Consensus guidance for monitoring individuals with islet autoantibody-positive pre-stage 3 type 1 diabetes
(
- Contribution to journal › Article
-
Mark
The Influence of Pubertal Development on Autoantibody Appearance and Progression to Type 1 Diabetes in the TEDDY Study
(
- Contribution to journal › Article
-
Mark
Oral Insulin Delay of Stage 3 Type 1 Diabetes Revisited in HLA DR4-DQ8 Participants in the TrialNet Oral Insulin Prevention Trial (TN07)
(
- Contribution to journal › Article
-
Mark
HLA Class II (DR, DQ, DP) Genes Were Separately Associated With the Progression From Seroconversion to Onset of Type 1 Diabetes Among Participants in Two Diabetes Prevention Trials (DPT-1 and TN07)
(
- Contribution to journal › Article
-
Mark
Anxiety, depression and quality of life in relation to SARS-CoV-2 antibodies in individuals living with diabetes during the second wave of COVID-19
(
- Contribution to journal › Article
-
Mark
Childhood screening for type 1 diabetes comparing automated multiplex Antibody Detection by Agglutination-PCR (ADAP) with single plex islet autoantibody radiobinding assays
(
- Contribution to journal › Article
-
Mark
Progression to type 1 diabetes in the DPT-1 and TN07 clinical trials is critically associated with specific residues in HLA-DQA1-B1 heterodimers
(
- Contribution to journal › Article
-
Mark
Type 1 diabetes, celiac disease, and autoimmune thyroiditis autoantibodies in population-based type 2 diabetes patients
(
- Contribution to journal › Article
-
Mark
Looking back at the TEDDY study : lessons and future directions
2024) In Nature Reviews Endocrinology(
- Contribution to journal › Scientific review